2003
DOI: 10.1128/jvi.77.15.8272-8279.2003
|View full text |Cite
|
Sign up to set email alerts
|

Exogenous Interleukin-12 Protects against Lethal Infection with Coxsackievirus B4

Abstract: Infections with the group B coxsackieviruses either can be asymptomatic or can lead to debilitating chronic diseases. To elucidate the mechanism by which these viruses cause chronic disease, we developed a mouse model of chronic pancreatitis by using a virulent variant of coxsackievirus B4, CVB4-V. Infection with CVB4-V results in an early, severe pancreatitis, which can lead to mortality or progress to chronic pancreatitis. Chronic pancreatitis, in this model, is due to immunopathological mechanisms. We inves… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
21
0

Year Published

2004
2004
2012
2012

Publication Types

Select...
7
1

Relationship

2
6

Authors

Journals

citations
Cited by 27 publications
(23 citation statements)
references
References 34 publications
2
21
0
Order By: Relevance
“…If true, then a prediction of the model is that modulation of either the angiogenic or immune response during CVB4-V infection would be beneficial. We have recently shown that immune modulation via cytokine (interleukin-12) administration protects the exocrine pancreas and prevents morbidity and mortality during CVB4-V infection (32). Since the inflammatory milieu induced by CVB4 may influence disease progression, future studies will examine global gene expression early in the infection process to identify candidate genes that influence the outcome of infection.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…If true, then a prediction of the model is that modulation of either the angiogenic or immune response during CVB4-V infection would be beneficial. We have recently shown that immune modulation via cytokine (interleukin-12) administration protects the exocrine pancreas and prevents morbidity and mortality during CVB4-V infection (32). Since the inflammatory milieu induced by CVB4 may influence disease progression, future studies will examine global gene expression early in the infection process to identify candidate genes that influence the outcome of infection.…”
Section: Discussionmentioning
confidence: 99%
“…For CVB4-V infections, a dose of 50 PFU was used. Because CVB4-V-infected mice develop exocrine pancreatic insufficiency (35), mice were given supplements of pancreatic enzymes (1 mg of pancreatin per ml) and sucrose (10%) in their drinking water to minimize morbidity (32). Mice were allowed to eat and drink ad libitum.…”
Section: Methodsmentioning
confidence: 99%
“…Results from preliminary experiments indicated that 0.5 g of IL-12 was optimal for protective efficacy, and no toxicity has been observed with this i.n. dose of IL-12 (15,21). Control mice received vehicle alone 24 h before infection.…”
Section: Methodsmentioning
confidence: 99%
“…Two days after V-virus infection, there was a trend of elevated serum amylase and lipase in K8-null and K18-null mice compared to their respective WT and heterozygous counterparts ( Table 2). The increased resistance of WT, heterozygous and K18-null mice to lethality by CVB4-V compared to published data in WT mice 21 could be due to differences in genetic background or age. Collectively, these data demonstrate that K8-null, but not K18-null, renders mice more susceptible to death by CVB4-V virus-induced pancreatitis.…”
Section: Virus Infectionmentioning
confidence: 77%
“…For example, IL-4-null mice survive CVB4-V infection, and normal mice administered IL-12 are protected from CVB4-V infection possibly due to increased IFNγ levels. 21,40 During CVB4 infection, the immunological response of a Th2-skewed pancreatic milieu during recovery co-insides with, and likely favors, acinar cell proliferation.…”
Section: Cell Health and Cytoskeletonmentioning
confidence: 99%